Repositorio de Universidad Autónoma de Chile.
metadata only
Clinical features of 314 patients with relapsing-remitting multiple sclerosis [Esclerosis múltiple recurrente remitente en el sector público de salud de chile. descripción clínica de 314 pacientes]
Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). Diagnostic confirmation and programmed follow up of these patients is carried out
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).#910159
- Treatment of Multiple Sclerosis With Copaxone and Albuterol#911448
- Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis#801587
- Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab#873586
- Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis#846830
Record · ID 947547
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive